Medical and Genetic Privacy

The ÀÏ°ÄÃÅ¿ª½±½á¹û works in courts, legislatures, and communities to defend and preserve the individual rights and liberties that the Constitution and the laws of the United States guarantee everyone in this country.

Privacy and Technology issue image

What's at Stake

Medical and genetic information can reveal some of the most personal and private data about us, and maintaining control over that information is crucial. As medical records are increasingly digitized and genetic sequencing becomes faster and cheaper, threats to our privacy and autonomy intensify. Whether it is police seeking to search medical records or conduct DNA tests without a warrant, or private corporations patenting human genes, the ÀÏ°ÄÃÅ¿ª½±½á¹û is standing up for your rights.

The ÀÏ°ÄÃÅ¿ª½±½á¹û has long fought to preserve the privacy of sensitive medical records and genetic information. For example, in Oregon Prescription Drug Monitoring Program v. Drug Enforcement Administration, we argued that law enforcement must get a probable cause warrant from a judge before requesting confidential prescription records from a state prescription tracking database. In Maryland v. King, we filed a brief in the U.S. Supreme Court opposing the drastic expansion of state DNA databases to include DNA samples from people who have been arrested but not yet convicted. In a 2004 case, we even asked a Florida court to protect the confidentiality of Rush Limbaugh’s medical records against unreasonable government search.

We have also consistently opposed attempts to infringe on people’s autonomy in making medical decisions. In 1965, the ÀÏ°ÄÃÅ¿ª½±½á¹û filed a friend-of-the-court brief in Griswold v. Connecticut, a landmark case where the Supreme Court struck down a state prohibition on the prescription, sale, or use of contraceptives, even for married couples, and recognized a right to privacy surrounding intimate medical and family planning decisions. More recently, in Association for Molecular Pathology v. Myriad Genetics, the ÀÏ°ÄÃÅ¿ª½±½á¹û successfully persuaded the Supreme Court to invalidate patents on two genes associated with hereditary breast and ovarian cancer, thus removing barriers to scientific research and treatment.

Medical and genetic information can reveal some of the most personal and private data about us, and maintaining control over that information is crucial. As medical records are increasingly digitized and genetic sequencing becomes faster and cheaper, threats to our privacy and autonomy intensify. Whether it is police seeking to search medical records or conduct DNA tests without a warrant, or private corporations patenting human genes, the ÀÏ°ÄÃÅ¿ª½±½á¹û is standing up for your rights.

The ÀÏ°ÄÃÅ¿ª½±½á¹û has long fought to preserve the privacy of sensitive medical records and genetic information. For example, in Oregon Prescription Drug Monitoring Program v. Drug Enforcement Administration, we argued that law enforcement must get a probable cause warrant from a judge before requesting confidential prescription records from a state prescription tracking database. In Maryland v. King, we filed a brief in the U.S. Supreme Court opposing the drastic expansion of state DNA databases to include DNA samples from people who have been arrested but not yet convicted. In a 2004 case, we even asked a Florida court to protect the confidentiality of Rush Limbaugh’s medical records against unreasonable government search.

We have also consistently opposed attempts to infringe on people’s autonomy in making medical decisions. In 1965, the ÀÏ°ÄÃÅ¿ª½±½á¹û filed a friend-of-the-court brief in Griswold v. Connecticut, a landmark case where the Supreme Court struck down a state prohibition on the prescription, sale, or use of contraceptives, even for married couples, and recognized a right to privacy surrounding intimate medical and family planning decisions. More recently, in Association for Molecular Pathology v. Myriad Genetics, the ÀÏ°ÄÃÅ¿ª½±½á¹û successfully persuaded the Supreme Court to invalidate patents on two genes associated with hereditary breast and ovarian cancer, thus removing barriers to scientific research and treatment.

Support our on-going litigation and advocacy work